Oral health is a major driver of ischemic stroke risk
People with gum disease plus cavities have a significantly increased risk of suffering an ischemic stroke compared to those with a healthy mouth, researchers report. The findings were… read more.
People with gum disease plus cavities have a significantly increased risk of suffering an ischemic stroke compared to those with a healthy mouth, researchers report. The findings were… read more.
Inspire Medical Systems Inc. published Inspire V clinical outcomes data from its Singapore clinical study as well as the Company’s limited market release in the United States including… read more.
When older adults living in nursing homes are prescribed the pain medicine tramadol alongside certain antidepressants, their risk of seizures may go up, according to a study published… read more.
Medtronic announced the results from the Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial now published in the distinguished Journal of the American Medical… read more.
Researchers report that traumatic brain injuries (TBI) in older adults are associated with new cases of dementia, use of home care services, and admission to long-term care. The… read more.
Neurocrine Biosciences, Inc. presented new data from the open-label KINECT-HD2 study demonstrating an established long-term safety profile, tolerability and sustained improvements in chorea severity through three years of… read more.
Newron Pharmaceuticals announced that it will present three posters at the upcoming 38th Congress of the European College of Neuropsychopharmacology taking place in Amsterdam, the Netherlands, from October 11… read more.
Research supported by the National Institutes of Health (NIH) shows that repeated head impacts from contact sports can cause early and lasting changes in the brains of young-… read more.
Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer’s disease. The diagnostic is intended for use in primary care. Using a tablet… read more.
Eisai Co., Ltd. announced that the in-house discovered and developed orexin receptor antagonist Dayvigo (brand name in China: “达卫可®“ generic name: lemborexant) has launched in China for the… read more.
NICE (UK): Idebenone is recommended, within its marketing authorisation, as an option for treating visual impairment in Leber’s hereditary optic neuropathy (LHON) in people 12 years and over…. read more.
Alexion, AstraZeneca Rare Disease, will present four abstracts, including one oral presentation, from its leading rare neurology portfolio at the European Committee for Treatment and Research in Multiple… read more.
Advertisment